Brian Goff

Insider Reports History

Location
Cambridge, CT
Signature
/s/ William Cook, as Attorney in Fact for Brian Goff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Goff:

Company Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Common stock 143,103 $3,876,660 $27.09 30 Dec 2025 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Performance share units 0 $3,399,519 $44.39 30 Dec 2025 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Restricted stock units 0 $1,279,440 $35.54 08 Aug 2025 Direct
Intellia Therapeutics, Inc. Director Common Stock 23,409 $194,762 $8.32 11 Jun 2025 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock options (right to buy) 142,500 01 Mar 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11,450 11 Jun 2025 Direct
ALEXION PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Common Stock, par value $.0001 per share 0 $177.00 21 Jul 2021 Direct
ALEXION PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Option to Purchase Common Stock 0 $155.01 21 Jul 2021 Direct

Insider Reports Filed by Brian Goff

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AGIO AGIOS PHARMACEUTICALS, INC. 30 Dec 2025 6 -$506,664 4 Chief Executive Officer, Director 02 Jan 2026, 20:16
AGIO AGIOS PHARMACEUTICALS, INC. 08 Aug 2025 3 -$406,487 4 Chief Executive Officer, Director 12 Aug 2025, 16:24
AGIO AGIOS PHARMACEUTICALS, INC. 24 Jun 2025 6 -$627,198 4 Chief Executive Officer, Director 26 Jun 2025, 17:22
NTLA Intellia Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
AGIO AGIOS PHARMACEUTICALS, INC. 01 Mar 2025 8 -$460,136 4 Chief Executive Officer, Director 04 Mar 2025, 16:10
AGIO AGIOS PHARMACEUTICALS, INC. 08 Aug 2024 3 -$474,140 4 Chief Executive Officer, Director 12 Aug 2024, 17:15
NTLA Intellia Therapeutics, Inc. 13 Jun 2024 0 $0 3 Director 17 Jun 2024, 17:15
NTLA Intellia Therapeutics, Inc. 13 Jun 2024 2 $0 4 Director 17 Jun 2024, 17:14
AGIO AGIOS PHARMACEUTICALS, INC. 05 Jun 2024 3 -$591,697 4 Chief Executive Officer, Director 07 Jun 2024, 16:25
AGIO AGIOS PHARMACEUTICALS, INC. 01 Mar 2024 5 -$135,361 4 Chief Executive Officer, Director 05 Mar 2024, 16:10
AGIO AGIOS PHARMACEUTICALS, INC. 20 Jan 2024 3 -$165,221 4 Chief Executive Officer, Director 24 Jan 2024, 16:20
AGIO AGIOS PHARMACEUTICALS, INC. 05 Jan 2024 3 -$277,397 4 Chief Executive Officer, Director 09 Jan 2024, 16:28
AGIO AGIOS PHARMACEUTICALS, INC. 08 Aug 2023 3 -$259,335 4 Chief Executive Officer, Director 10 Aug 2023, 16:07
AGIO AGIOS PHARMACEUTICALS, INC. 28 Jun 2023 3 -$324,694 4 Chief Executive Officer, Director 30 Jun 2023, 16:05
AGIO AGIOS PHARMACEUTICALS, INC. 01 Mar 2023 2 $0 4 Chief Executive Officer, Director 03 Mar 2023, 15:06
AGIO AGIOS PHARMACEUTICALS, INC. 08 Aug 2022 0 $0 3/A Chief Executive Officer, Director 09 Aug 2022, 17:08
AGIO AGIOS PHARMACEUTICALS, INC. 08 Aug 2022 2 $0 4 Chief Executive Officer, Director 09 Aug 2022, 16:50
ALXN ALEXION PHARMACEUTICALS, INC. 21 Jul 2021 2 -$2,178,045 4 EVP & Chief Commercial Officer 23 Jul 2021, 16:42
ALXN ALEXION PHARMACEUTICALS, INC. 14 Jul 2021 2 $0 4 EVP & Chief Commercial Officer 16 Jul 2021, 16:43
ALXN ALEXION PHARMACEUTICALS, INC. 08 Jun 2021 1 -$192,222 4 EVP & Chief Commercial Officer 09 Jun 2021, 16:52